Sterimar vs Saline Sprays in Nasal Surgical Aftercare - a Blinded, Randomised Trial
NCT ID: NCT00595608
Last Updated: 2008-01-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
120 participants
INTERVENTIONAL
2008-02-29
2010-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
There is currently no level 1 evidence in literature to support the use of any particular preparation over others in nasal surgical aftercare.
We propose to conduct a single blinded, randomised trial comparing saline sprays vs Sterimar, a commercially available aerosolised isotone saline solution, comparing patients' symptom scores following septal surgery.
The trial will help to establish efficacy and symptom control and advantages of one solution and delivery device over the other.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trial of Directed High-dose Nasal Steroids on Residual Smell Loss in Sinus Patients After Sinus Surgery
NCT01814618
Steroid Treatment for Elimination of Rebound Obstruction From Intranasal Decongestants
NCT07168148
Nasal Outcomes Using Saline Irrigations After Endonasal Pituitary Surgery
NCT05659524
The Use of Antibiotic Sinonasal Rinse After Sinus Surgery
NCT02218307
Pre-operative Steroids in CRSsP
NCT05095961
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Sterimar vs Saline Sprays in nasal surgical aftercare - a blinded, randomised trial.
Gundula Thiel, Andy Evans, Kim Ah-See
Background
Patients undergoing nasal surgery commonly experience a variety of symptoms in the post-operative period including blockage, running, pain, bleeding and reduction in sense of smell. A variety of preparations are currently recommended for symptomatic relief in the post operative period. These include saline irrigations and sniffs, steam inhalations, decongestants and steroid drops. These are intended to reduce swelling and crusting and their resultant symptoms.
There is currently no level 1 evidence in literature to support the use of any particular preparation over others in nasal surgical aftercare.
A recent randomised controlled trial carried out in this department, comparing use of xylometazoline based decongestants vs Sterimar seawater nasal spray, showed a lower pain scoring in the Sterimar group but no other significant differences. This study is as yet unpublished.
Sterimar spray is a spray made from seawater which is diluted to make the solution isotonic.
Traditionally, other forms of Saline sniffs and rinses are also used for the above mentioned applications.
It is easy to make up an isotonic saline solution, using 5 grams of salt (1 teaspoon) for every ½ litre of boiled water. This can then, after cooling off, be applied to the nasal cavities with the help of a standard 10 ml syringe which is provided to the patient at discharge.
As Sterimar is not yet on the hospital formulary, the cost for the treatment is currently borne by the patient. For the duration of the study, patients randomized into the Sterimar group will be provided with the medication free of charge.
We consider it unlikely that patients randomised into the saline spray group will supplement this treatment by buying further saline sprays from the chemist at their own expense.
To establish this and to follow up patients after the trial period, we will establish a research clinic. Patients will be reviewed in a clinic dedicated to patients taking part in this trial approximately 2 weeks after surgery, after completion of the trial period.
The trial will help to establish efficacy and symptom control and advantages of one solution and delivery device over the other.
If home-made saline sprays could be used to similar effect as Sterimar, the cost for this form of surgical aftercare could be lowered significantly, both for the patient and the NHS.
We propose to conduct a single blinded, randomised trial comparing saline sprays vs Sterimar, a commercially available aerosolised isotone saline solution, comparing patients' symptom scores following septal surgery.
The MHRA confirmed that neither the Sterimar nor the home made saline spray are considered Investigational Medicinal Products.
Methodology
Setting
ENT unit, Aberdeen Royal Infirmary, teaching hospital
Inclusions / exclusions
Patients undergoing septoplasty and septoplasty in conjunction with turbinate surgery will be recruited. Those undergoing additional procedures including polypectomy will be excluded, as will all patients whose post-operative recommendations are for steroids or other take home medications that may bias results.
Recruitment
Patients fitting the inclusion criteria will be approached in the Outpatients clinic. The decision for septoplasty +/- turbinate surgery will be made there and consent for the operation will be taken. A patient information sheet will be administered by the lead investigator or other medical staff on the same day, allowing the patient ample time to discuss the matter with relatives and medical staff. Patients will be left to read the information sheet and then re-approached to assess willingness to be included in the trial. The procedure of the trial will be further explained and informed consent to take part will be obtained. Patients will retain the patient information sheet as well as receive a scoring sheet containing visual analogue scales to assess symptoms - pain, running, sense of smell, bleeding, blockage. A questionnaire assessing use of post-operative analgesia for 7 days on a daily basis will also be included.
All these forms will be on appropriately headed paper. A clear explanation of how to complete the assessment sheet will be given. The patient will be approached again on the pre-operative morning and Patients will be randomised using a randomisation schedule generated by NHS Grampian Research \& Development Dept.
can withdraw his/her consent to the trial at any time. Randomisation
Patients will be randomised using a randomisation schedule generated by NHS Grampian Research \& Development Dept.
Treatment
Based on the randomisation, patients will be given one of either saline sprays or Sterimar Physiological Sea Water Microspray. Instructions regarding use will be given including frequency and technique.
Outcome measures
On the 3rd and 7th postoperative day, patients will complete the symptom assessment sheet judging their symptoms on that day.
The patient should record painkillers needed on the Analgesia Requirement Sheet on a daily basis for 7 days.
The patients will also be provided with an EQ-5D health questionnaire, which is well validated and has referent look up values for populations of ill and healthy patients.
These will be returned in a pre-paid envelope and will be identifiable only by the patients' study number retained in the randomisation program.
Analysis
Visual analogue scales will be analyzed by investigators blinded to which treatment has been administered.
Results will be further analysed comparing scores achieved for those taking saline sniffs and those taking Sterimar. Tests of statistical significance will be performed to establish if either preparation is superior in symptom control. Analgesia use will be taken into consideration.
To select a difference in symptom scores on a visual analogue scale of 10mm or more at the level of significance with 80% power, a sample size of 60 patients is required in each arm of the trial. This is assuming a standard deviation of 19mm, which was demonstrated in the study previously conducted in this department.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Nasal Sterimar spray
Sterimar Spray
Post-op nasal spray, three times a day
2
Nasal saline spray
Generic homemade nasal saline spray (salt and water)
post op nasal saline spray in syringe, three times a day
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sterimar Spray
Post-op nasal spray, three times a day
Generic homemade nasal saline spray (salt and water)
post op nasal saline spray in syringe, three times a day
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NHS Grampian
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
NHS Grampian
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kim W Ah-See, MD, FRCS
Role: PRINCIPAL_INVESTIGATOR
NHS Grampian
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Otorhinolaryngology, Aberdeen Royal Infirmary
Aberdeen, Scotland, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
07/S0802/45
Identifier Type: -
Identifier Source: secondary_id
07/S0802/45
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.